FundedIQ
Biotechnology

60 Degrees Pharma: Funding, Investors & Team (Nov 2026)

60 Degrees Pharmaceuticals creates and markets innovative medications for the treatment and prevention of infectious diseases. Among their offerings are ARAKODA for malaria prevention and COVID-19 treatments.

60degreespharma.com LinkedIn Washington, United States 1-10 employees
Total raised
$7.8M
Rounds
3
Latest
Undisclosed round
Jul 2025

60 Degrees Pharma has raised $7.8M across 3 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Jul 2025.

That round is below the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

60 Degrees Pharma Company Profile and Key Stats

Total funding raised
$7.8M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$5.0M in Jul 2025
Employees
1-10
reported band
Headquarters
Washington, United States

Latest funding round on record: Jul 2025.

60 Degrees Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
$5.0M
Undisclosed round
$1.0M
Undisclosed round
$1.8M

60 Degrees Pharma raised $1.8M in an undisclosed round announced in May 2023.

1.7 years later, an undisclosed round of $1.0M was announced in Jan 2025.

6 months later, an undisclosed round of $5.0M was announced in Jul 2025.

60 Degrees Pharma Founders and Leadership Team

Name
Role
Contact
Geoffrey Dow
Founder
—

No contact details are on record for this team yet.

60 Degrees Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
30,615
$7.8M

60 Degrees Pharma's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like 60 Degrees Pharma in Biotechnology and Washington

Companies Similar to 60 Degrees Pharma

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

60 Degrees Pharma Funding FAQs

What does 60 Degrees Pharma do?

60 Degrees Pharmaceuticals creates and markets innovative medications for the treatment and prevention of infectious diseases. Among their offerings are ARAKODA for malaria prevention and COVID-19 treatments.

How much funding has 60 Degrees Pharma raised?

60 Degrees Pharma has raised $7.8M across 3 rounds on record. The most recent is an undisclosed round of $5.0M announced in Jul 2025.

When did 60 Degrees Pharma last raise funding?

60 Degrees Pharma's most recent funding round on record is an undisclosed round of $5.0M, announced in Jul 2025.

Who founded 60 Degrees Pharma?

FundedIQ lists Geoffrey Dow (Founder) at 60 Degrees Pharma.

Where is 60 Degrees Pharma headquartered?

60 Degrees Pharma is based in Washington, District of Columbia, United States.

How many employees does 60 Degrees Pharma have?

60 Degrees Pharma is in the 1-10 employee band.

How does 60 Degrees Pharma's funding compare to other Biotechnology startups?

60 Degrees Pharma's latest round of $5.0M is below the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's 60 Degrees Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 60 Degrees Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.